Jazz Pharmaceuticals' PTSD drug fails in mid-stage trial

In this article:

Dec 21 (Reuters) - Jazz Pharmaceuticals said on Thursday its post-traumatic stress disorder drug failed in a mid-stage study. (Reporting by Sriparna Roy in Bengaluru; Editing by Krishna Chandra Eluri)

Advertisement